Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
Tools
Zhuang, G, Schmidt, M, Yao, J, Wu, X, Kaminker, JS, Jurinka, SS, Kolumam, G, Chung, AS, Jubb, A, Modrusan, Z, Ozawa, T, James, CD, Phillips, H, Haley, B, Tam, RNW, Clermont, AC, Cheng, JH, Yang, SX, Swain, SM, Chen, D, Scherer, SJ, Koeppen, H, Yeh, RF, Yue, P, Stephan, JP, Hegde, P, Ferrara, N, Singh, M and Bais, C (2013) Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies. CLINICAL CANCER RESEARCH. pp. 3681-3692.
Official URL: http://sfx.eu.novartis.net:9004/sfx_local?sid?url_...
Item Type: | Article |
---|---|
Additional Information: | pubid: 115 nvp_institute: NIBR contributor_address: Genentech Inc, San Francisco, CA 94131 USA mallika.singh@novartis.com; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA, Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA USA ; NCI, NIH, Div Canc Treatment & Diag, Nat Clin Target Validat Lab, Bethesda, MD USA ; Medstar Washington Hosp, Washington Canc Inst, Washington, DC USA ; Novartis Inst Biomed Res, Emeryville, CA USA ; Genentech Inc, San Francisco, CA 94131 USA; Bais, C; Genentech Inc, 1 DNA Way, San Francisco, CA 94131 USA |
Date Deposited: | 13 Oct 2015 13:13 |
Last Modified: | 13 Oct 2015 13:13 |
URI: | https://oak.novartis.com/id/eprint/21953 |